On the recordDecember 1, 2022
I ask unanimous consent that the committee-reported substitute amendment be withdrawn; that the McConnell substitute amendment at the desk be agreed to; that the bill, as amended, be considered read a third time and passed; and that the motion to reconsider be considered made and laid upon the table. The ACTING PRESIDENT pro tempore. Without objection, it is so ordered. The committee-reported amendment in the nature of a substitute was withdrawn. The amendment (No. 6504) in the nature of a substitute was agreed to, as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE. This Act may be cited as the ``Cardiovascular Advances in Research and Opportunities Legacy Act''. SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES. (a) In General.--The Secretary of Health and Human Services (referred to in this section as the ``Secretary'') shall, as appropriate, continue activities related to research, education, and awareness of valvular heart diseases. (b) NIH Research Related to Valvular Heart Diseases.-- (1) In general.--The Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, may support or conduct research regarding valvular heart diseases.…
Source
govinfo.gov




